Table 1 Patient characteristics
Characteristic | Temporary CVC (n = 137) | Permanent VA (n = 256) | P value |
|---|---|---|---|
Age (year) | 67.4 ± 14.4 | 66.2 ± 14.7 | 0.443 |
Male sex, n (%) | 92 (67.2) | 181 (70.7) | 0.467 |
Predialysis nephrology care | < 0.001* | ||
< 6 months, n (%) | 82 (59.9) | 45 (17.6) | |
6–12 months, n (%) | 7 (5.1) | 29 (11.3) | |
1–2 years, n (%) | 13 (9.5) | 55 (21.5) | |
2–5 years, n (%) | 20 (14.6) | 71 (27.7) | |
> 5 years, n (%) | 15 (10.9) | 56 (21.9) | |
Kidney disease due to ESRD | 0.004* | ||
DKD, n (%) | 45 (32.8) | 101 (39.4) | |
CGN, n (%) | 22 (16.1) | 47 (18.4) | |
HN, n (%) | 32 (23.4) | 57 (22.3) | |
Other CKDs, n (%) | 20 (14.6) | 44 (17.2) | |
RPGN, n (%) | 13 (9.5) | 7 (2.7) | |
AKI, n (%) | 5 (3.6) | 0 (0.0) | |
Serum creatinine (mg/dL) | 7.90 (6.76–9.69) | 8.64 (7.28–10.37) | 0.017* |
eGFR (mL/min per 1.73 m2) | 5.34 (4.36–6.65) | 5.03 (4.14–6.06) | 0.057 |
Hemoglobin (g/dL) | 8.7 ± 1.9 | 9.3 ± 1.4 | < 0.001* |
The time from the creation to the first cannulation of AVFs (days) | 8 (6–12) | 66 (21–139) | < 0.001* |
The time from HD initiation to the creation of AVFs (days) | 10 (6–17) | ||
The time from HD initiation to the first cannulation of AVFs (days) | 19 (14–24) |